[1] CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China[J]. CA Cancer J Clin, 2016, 66(2): 115. doi: 10.3322/caac.21338
[2] CAI Y, YU X, HU S, et al. A brief review on the mechanisms of miRNA regulation[J]. Gen Pro Bio, 2009, 7(4): 147. doi: 10.1016/S1672-0229(08)60044-3
[3] YOSHINO H, ENOKIDA H, ITESAKO T, et al. Tumor-suppressive microRNA143-145 cluster targets hexokinase-2 in renal cell carcinoma[J]. Cancer Sci, 2013, 104(12): 1567. doi: 10.1111/cas.12280
[4] MIHALY Z, SZTUPINSZKI Z, SUROWIAK P, et al. A comprehensive overview of targeted therapy in metastatic renal cell carcinoma[J]. Curr Cancer Drug Targets, 2012, 12(7): 857. doi: 10.2174/156800912802429265
[5] PAPADOPOULOS EI, YOUSEF GM, SCORILAS A, et al. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes[J]. Biomed Pharmacother, 2015, 70: 33. doi: 10.1016/j.biopha.2014.12.043
[6] ESCUDIER B, PORTA C, SCHMIDINGER M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosistreatment and follow-up[J]. Ann Oncol, 2016, 27: 58.
[7] KOVACOVA J, POPRACH A, BUCHLER T, et al. MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma[J]. Clin Chem Lab Med, 2018, 56(9): 1426. doi: 10.1515/cclm-2017-0861
[8] 谭亚, 周贤. MicroRNA-143与常见肿瘤关系的研究进展[J]. 西南军医, 2016, 18(6): 555. doi: 10.3969/j.issn.1672-7193.2016.06.020
[9] 龚彬彬. 白花丹素通过PI3K/AKT、MCM5抑制肾细胞癌增殖和侵袭转移的分子机制研究[D]. 南昌: 南昌大学, 2019.
[10] 牛荣, 王转兄, 白悦, 等. miR-143-3p在胃癌组织中的表达和临床意义研究以及生信分析[J]. 中国普外基础与临床杂志, 2019, 26(5): 538.
[11] 陈超, 张伟丽, 冯长松. lncRNA PCAT19靶向miR-143-3p通过信号通路PI3K/Akt对甲状腺癌细胞增殖和凋亡的影响及机制[J]. 中国老年学杂志, 2020, 40(8): 1712. doi: 10.3969/j.issn.1005-9202.2020.08.043
[12] LI M, WANG Y, SONG Y, et al. Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma[J]. Int J Clin Exp Pathol, 2014, 7(11): 7597.
[13] BRITTANY N, LASSEIGNE, JAMES D, et al. The role of DNA methylation in renal cell carcinoma[J]. Mol Diagn Ther, 2018, 22(4): 431. doi: 10.1007/s40291-018-0337-9
[14] GUJAR H, WEISENBERGERDJ, LIANG G, et al. The Roles of human DNA methyltransferases and their isoforms in shaping the epigenome[J]. Genes, 2019, 10(2): 172. doi: 10.3390/genes10020172
[15] 周辉. MicroRNA-200b通过靶向DNMT3A及DNMT3B在肾细胞癌中调控MEG3表达[D]. 武汉: 华中科技大学, 2016.
[16] ZHANG X, DONG Y, TI H, et al. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas[J]. Hum Pathol, 2013, 44(11): 2571. doi: 10.1016/j.humpath.2013.07.002